Cargando…
Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor
Plerixafor is widely used as up-front treatment with G-CSF to enhance peripheral blood hematopoietic stem cell output in patients failing previous mobilizations. Less frequently, plerixafor is used to rescue an unsatisfactory mobilization following chemotherapy (CT) and G-CSF. This study investigate...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866585/ https://www.ncbi.nlm.nih.gov/pubmed/36675546 http://dx.doi.org/10.3390/jcm12020618 |
_version_ | 1784876128197935104 |
---|---|
author | Valentini, Caterina Giovanna Pellegrino, Claudio Putzulu, Rossana Bonanni, Matteo Massini, Giuseppina Orlando, Nicoletta Forni, Franca Bianchi, Maria Piccirillo, Nicola Teofili, Luciana |
author_facet | Valentini, Caterina Giovanna Pellegrino, Claudio Putzulu, Rossana Bonanni, Matteo Massini, Giuseppina Orlando, Nicoletta Forni, Franca Bianchi, Maria Piccirillo, Nicola Teofili, Luciana |
author_sort | Valentini, Caterina Giovanna |
collection | PubMed |
description | Plerixafor is widely used as up-front treatment with G-CSF to enhance peripheral blood hematopoietic stem cell output in patients failing previous mobilizations. Less frequently, plerixafor is used to rescue an unsatisfactory mobilization following chemotherapy (CT) and G-CSF. This study investigates if pre-collection factors affect the CD34+ cell harvest in chemotherapy and G-CSF mobilizations rescued by plerixafor. Clinical and hematological data relative to patients, mobilization, and apheresis products were retrospectively examined. The outcome was completing a target cell dose ≥ 2 × 10(6) CD34+ cells/kg at first apheresis. The effect exerted on the outcome by patient- and disease-related factors was investigated by univariate and multivariate logistic regression analysis. The analysis included data from 42 patients affected by hematological (39 patients) and non-hematological malignancies (three patients). Twenty-nine patients (69%) attained the target cell dose at first apheresis. Twelve out of the remaining 13 patients received an additional plerixafor administration, and all accomplished the transplant dose at a second apheresis procedure. Day -1 CD34+ PB count (OR1.46, 95% CI 1.1–1.9, p = 0.008) and platelet count (OR1.0, 95% CI 1.0–1.0, p = 0.033) predicted the achievement of the target dose at first apheresis, independently of pre-mobilization CT, radiation therapy, and disease status at mobilization. At ROC curve analysis, the best cut-off value predicting the successful collection at first apheresis was 7.5/µL for Day -1 CD34+ cell count (AUC 0.830, 0.69 sensitivity, and 0.92 specificity) and 75 × 10(9)/L for Day -1 platelet count (AUC = 0.736, 0.65 sensitivity and 0.85 specificity). In conclusion, on-demand plerixafor rescue allows a successful stem cell collection, irrespectively of disease type and status, prior CT lines, and radiation exposure. Pre-apheresis CD34+ cells and platelet count predict the need for one or two aphereses. |
format | Online Article Text |
id | pubmed-9866585 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98665852023-01-22 Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor Valentini, Caterina Giovanna Pellegrino, Claudio Putzulu, Rossana Bonanni, Matteo Massini, Giuseppina Orlando, Nicoletta Forni, Franca Bianchi, Maria Piccirillo, Nicola Teofili, Luciana J Clin Med Article Plerixafor is widely used as up-front treatment with G-CSF to enhance peripheral blood hematopoietic stem cell output in patients failing previous mobilizations. Less frequently, plerixafor is used to rescue an unsatisfactory mobilization following chemotherapy (CT) and G-CSF. This study investigates if pre-collection factors affect the CD34+ cell harvest in chemotherapy and G-CSF mobilizations rescued by plerixafor. Clinical and hematological data relative to patients, mobilization, and apheresis products were retrospectively examined. The outcome was completing a target cell dose ≥ 2 × 10(6) CD34+ cells/kg at first apheresis. The effect exerted on the outcome by patient- and disease-related factors was investigated by univariate and multivariate logistic regression analysis. The analysis included data from 42 patients affected by hematological (39 patients) and non-hematological malignancies (three patients). Twenty-nine patients (69%) attained the target cell dose at first apheresis. Twelve out of the remaining 13 patients received an additional plerixafor administration, and all accomplished the transplant dose at a second apheresis procedure. Day -1 CD34+ PB count (OR1.46, 95% CI 1.1–1.9, p = 0.008) and platelet count (OR1.0, 95% CI 1.0–1.0, p = 0.033) predicted the achievement of the target dose at first apheresis, independently of pre-mobilization CT, radiation therapy, and disease status at mobilization. At ROC curve analysis, the best cut-off value predicting the successful collection at first apheresis was 7.5/µL for Day -1 CD34+ cell count (AUC 0.830, 0.69 sensitivity, and 0.92 specificity) and 75 × 10(9)/L for Day -1 platelet count (AUC = 0.736, 0.65 sensitivity and 0.85 specificity). In conclusion, on-demand plerixafor rescue allows a successful stem cell collection, irrespectively of disease type and status, prior CT lines, and radiation exposure. Pre-apheresis CD34+ cells and platelet count predict the need for one or two aphereses. MDPI 2023-01-12 /pmc/articles/PMC9866585/ /pubmed/36675546 http://dx.doi.org/10.3390/jcm12020618 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Valentini, Caterina Giovanna Pellegrino, Claudio Putzulu, Rossana Bonanni, Matteo Massini, Giuseppina Orlando, Nicoletta Forni, Franca Bianchi, Maria Piccirillo, Nicola Teofili, Luciana Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor |
title | Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor |
title_full | Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor |
title_fullStr | Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor |
title_full_unstemmed | Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor |
title_short | Day -1 CD34+ Cells and Platelet Count Predict the Number of Apheresis in Poor-Mobilizer Patients Rescued by Plerixafor |
title_sort | day -1 cd34+ cells and platelet count predict the number of apheresis in poor-mobilizer patients rescued by plerixafor |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866585/ https://www.ncbi.nlm.nih.gov/pubmed/36675546 http://dx.doi.org/10.3390/jcm12020618 |
work_keys_str_mv | AT valentinicaterinagiovanna day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT pellegrinoclaudio day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT putzulurossana day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT bonannimatteo day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT massinigiuseppina day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT orlandonicoletta day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT fornifranca day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT bianchimaria day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT piccirillonicola day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor AT teofililuciana day1cd34cellsandplateletcountpredictthenumberofapheresisinpoormobilizerpatientsrescuedbyplerixafor |